SkyePharma Restructures Debt as Flutiform Wins UK Approval
LONDON – After marathon negotiations, SkyePharma plc reached agreement on restructuring £83 million (US$131.2 million) of bond debt, avoiding the obligation to make payments – that it could not possibly have afforded – of £68.4 million in 2013 and £21.6 million in 2014.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter